A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

Clinical trial NCT05287126 · RECRUITING

Trial details

NCT number: NCT05287126
Sponsor: Pfizer
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2022-12-16
Primary completion: 2029-06-16
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.